Neuroendocrine Tumors

• 

  Subject Areas on Research

  • A DLL3-targeted antibody-drug conjugate eradicates high-grade pulmonary neuroendocrine tumor-initiating cells in vivo. 
  • A case report on metastatic ileal neuroendocrine neoplasm to the breast masquerading as primary breast cancer: A diagnostic challenge and management dilemma. 
  • A pilot genome-wide association study shows genomic variants enriched in the non-tumor cells of patients with well-differentiated neuroendocrine tumors of the ileum. 
  • Attenuation of the retinoblastoma pathway in pancreatic neuroendocrine tumors due to increased cdk4/cdk6. 
  • Calcitonin driven v-Ha-ras induces multilineage pulmonary epithelial hyperplasias and neoplasms. 
  • Choroidal metastatasis from a neuroendocrine tumor masquerading as choroidal melanoma. 
  • Embryonic lethal abnormal visual RNA-binding proteins involved in growth, differentiation, and posttranscriptional gene expression. 
  • Gastrointestinal manifestations of endocrine disease. 
  • Grading of well-differentiated pancreatic neuroendocrine tumors is improved by the inclusion of both Ki67 proliferative index and mitotic rate. 
  • Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States. 
  • Insights into Novel Prognostic and Possible Predictive Biomarkers of Lung Neuroendocrine Tumors. 
  • Intensity-modulated radiation therapy for anal malignancies: a preliminary toxicity and disease outcomes analysis. 
  • Lipid-rich variant of a pancreatic endocrine neoplasm in an endoscopic ultrasound-guided fine needle aspiration biopsy. 
  • Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study. 
  • Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review. 
  • NCCN practice guidelines for occult primary tumors. National Comprehensive Cancer Network. 
  • Neuroendocrine Neoplasms of the Appendix: A Review of the Literature. 
  • Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated nonsmall cell lung carcinoma. 
  • Neuroendocrine tumors, version 1.2015. 
  • Neuroendocrine tumors. 
  • O6-Methylguanine DNA Methyltransferase Status Does Not Predict Response or Resistance to Alkylating Agents in Well-Differentiated Pancreatic Neuroendocrine Tumors. 
  • Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study. 
  • Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors. 
  • Overexpression of SOX11 and TFE3 in Solid-Pseudopapillary Neoplasms of the Pancreas. 
  • Pancreatic FNA in 1000 cases: a comparison of imaging modalities. 
  • Pancreatic neuroendocrine tumors with involved surgical margins: prognostic factors and the role of adjuvant radiotherapy. 
  • Pathologic grade and tumor size are associated with recurrence-free survival in patients with duodenal neuroendocrine tumors. 
  • Platinum sensitivity in metastatic prostate cancer: does histology matter? 
  • Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors. 
  • Proceed with caution: liver transplantation for metastatic neuroendocrine tumors. 
  • Protein structure of fetal antigen 1 (FA1). A novel circulating human epidermal-growth-factor-like protein expressed in neuroendocrine tumors and its relation to the gene products of dlk and pG2. 
  • Resected pancreatic neuroendocrine tumors: patterns of failure and disease-related outcomes with or without radiotherapy. 
  • Resolution of hepatic encephalopathy following hepatic artery embolization in a patient with well-differentiated neuroendocrine tumor metastatic to the liver. 
  • SOX9: a useful marker for pancreatic ductal lineage of pancreatic neoplasms. 
  • Serotonin expression in pancreatic neuroendocrine tumors correlates with a trabecular histologic pattern and large duct involvement. 
  • Stimulation of Ki-ras ribozyme activity by RNA binding protein, NCp7, in vitro and in pancreatic tumor cell line, capan 1. 
  • Surgery versus intra-arterial therapy for neuroendocrine liver metastasis: a multicenter international analysis. 
  • Surgical management of hepatic neuroendocrine tumor metastasis: results from an international multi-institutional analysis. 
  • Synchronous resection of primary and liver metastases for neuroendocrine tumors. 
  • The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms. 
  • The role of endoscopy in the evaluation and management of patients with solid pancreatic neoplasia. 
  • Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated. 
  • Update on Surgical Management of Small Bowel Neuroendocrine Tumors. 
  • Use of Everolimus After Multivisceral Transplantation: A Report of Two Cases. 
  • Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas. 
• 

  Keywords of People

  • Yoo, Sua, Associate Professor of Radiation Oncology, Radiation Oncology